Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US0396971071
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG001WH4DQ3
ARDX
Ardelyx Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Ardelyx Inc
ISIN
US0396971071
TICKER
ARDX
MIC
XNAS
REUTERS
ARDX.OQ
BLOOMBERG
ARDX US
Thu, 15.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Thu, 15.10.2026       Ardelyx
US0396971071

SAN DIEGO, Oct. 14, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Ardelyx, Inc. (NASDAQ: ARDX) common stock between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). Ardelyx, Inc. develops and comme...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 14.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 14.10.2026       Ardelyx
US0396971071

Alert: Claims focus on alleged misrepresentations about payer utilization management and prescription pull-through, which allegedly slowed new-patient starts for IBSRELA while Ardelyx reaffirmed $240 million to $250 million in 2025 sales guidance.NEW YORK, Oct. 14, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP announces that a securities class act...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 14.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 14.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 13, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Peri...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Tue, 13.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Mon, 12.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Mon, 12.10.2026       Ardelyx
US0396971071

Additional presentations highlight the design of an ongoing Phase 3 study evaluating tenapanor in chronic idiopathic constipation and the impact of IBS-C symptom burden on quality of life Additional presentations highlight the design of an ongoing Phase 3 study evaluating tenapanor in chronic idiopathic constipation and the impact of IBS-C symptom...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Mon, 12.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Sun, 11.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Sat, 10.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Sat, 10.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 9, 2026) - WHY:Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx c...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Fri, 09.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 9, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Perio...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Fri, 09.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Thu, 08.10.2026       Ardelyx
US0396971071

NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encourage...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Thu, 08.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 07.10.2026       Ardelyx
US0396971071

NEW YORK, Oct. 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.So what: If you purchased Ardelyx common stock durin...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 07.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 7, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Perio...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 07.10.2026       Ardelyx
US0396971071

Notice to pension funds, asset managers, and fiduciaries: the lawsuit contends Ardelyx maintained its long-term revenue outlook for XPHOZAH and IBSRELA while payer access barriers were allegedly building, before an 18% single-session repricing of ARDX shares.NEW YORK, Oct. 7, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies institutional inv...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 06.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 6, 2026) - Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.So what: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Tue, 06.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Mon, 05.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Mon, 05.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 5, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Perio...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Mon, 05.10.2026       Ardelyx
US0396971071

Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Ardelyx, Inc. (NASDAQ: ARDX) common stock between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). Ardelyx, Inc. develops and commercializes medicines, including IBSRELA fo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Mon, 05.10.2026       Ardelyx
US0396971071

Presentations include real-world XPHOZAH® (tenapanor) data and new insights into hyperphosphatemia management and outcomes Presentations include real-world XPHOZAH® (tenapanor) data and new insights into hyperphosphatemia management and outcomes...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Sun, 04.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Sat, 03.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Sat, 03.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Fri, 02.10.2026       Ardelyx
US0396971071

NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.So what: If you purchased Ardelyx common stock durin...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Fri, 02.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 1, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Perio...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Thu, 01.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Thu, 01.10.2026       Ardelyx
US0396971071

A securities class action chronicles how Ardelyx allegedly reaffirmed billion-dollar sales targets for IBSRELA and XPHOZAH across 19 months while payer prior authorization and step edit barriers were allegedly slowing new-patient starts.NEW YORK, Oct. 1, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Ardelyx, Inc. (NASDAQ: ARDX) securities th...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Thu, 01.10.2026       Ardelyx
US0396971071

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encourag...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 30.09.2026       Ardelyx
US0396971071

San Diego, California--(Newsfile Corp. - September 30, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Ardelyx, Inc. (NASDAQ: ARDX) common stock between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). Ardelyx, I...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 30.09.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - September 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardel...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 30.09.2026       Ardelyx
US0396971071

Time-Sensitive: Allegations focus on Ardelyx's representations that its patient-access strategy was working, while more stringent prior authorization and step edit requirements were allegedly slowing new-patient starts for IBSRELA and XPHOZAH.NEW YORK, Sept. 30, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in Ardelyx, Inc. (NASDA...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 30.09.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 30.09.2026       Ardelyx
US0396971071

Recognition includes Life Sciences Manufacturer CEO of the Year, Podcast Initiative, and Marketing Team of the Year Recognition includes Life Sciences Manufacturer CEO of the Year, Podcast Initiative, and Marketing Team of the Year...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 30.09.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - September 29, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Pe...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Tue, 29.09.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - September 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If yo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Tue, 29.09.2026       Ardelyx
US0396971071

NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Mon, 28.09.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - September 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If yo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Sat, 26.09.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Sat, 26.09.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - September 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If yo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Thu, 24.09.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - September 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If yo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Thu, 24.09.2026       Ardelyx
US0396971071

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encour...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Thu, 24.09.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - September 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Pe...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Thu, 24.09.2026       Ardelyx
US0396971071

Ardelyx's Chief Commercial Officer, Eric Foster, is named as an individual defendant in a securities class action alleging he assured investors the Company's patient-access strategy was working while payer prior authorization and step edit requirements were allegedly restricting IBSRELA and XPHOZAH prescriptions.NEW YORK, Sept. 24, 2026 /PRNewswir...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink
Wed, 23.09.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - September 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If yo...
Read more
Ardelyx
Technical Analysis Termsheets Terminal
Permalink